-
High-resolution genomic map gives scientists unprecedented view of brain development
09/13/2018
The research will aid basic understanding of brain development, and also help understanding cellular origins of brain disorders caused by errors in development.
-
Discovery of a cancer promoter offers pathway to overcome drug resistance
09/12/2018
Geneticists discovered that mTORC3 aids cancers' resistance to rapamycin and related drugs, offering the promise of new drug therapies to treat cancers.
-
St. Jude researchers solve a central mystery of a baffling high-risk leukemia
09/12/2018
Read the latest on the roots of mixed phenotype acute leukemia (MPAL), including how the findings might affect treatment of patients with the high-risk cancer.
-
CBS Sports HQ To Stream Live Fantasy Football Telethon on Labor Day
08/28/2018
CBS Sports HQ will partner with St. Jude to support Childhood Cancer Awareness Month by streaming a live Fantasy Football Telethon on Labor Day.
-
Immune system prioritizes distinct immune responses in infants with flu
08/28/2018
Flu infections pose a significant risk to infants. Read about the T cells the immune system relies on to repair lung damage in infants infected with influenza.
-
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor
08/23/2018
Read about what happened when researchers looked beyond mutations to understand the developmental origins and vulnerabilities of rhabdomyosarcoma.
-
St. Jude achieves consecutive highest rating from National Cancer Institute during Cancer Center renewal grant
08/22/2018
St. Jude is the first and only NCI-designated Comprehensive Cancer Center that is devoted solely to children.
-
2017 FedExCup Champion Justin Thomas and NBC’s THE TONIGHT SHOW host Jimmy Fallon Competed in High-Stakes Golf Competition
08/16/2018
Ahead of the 2018 FedExCup Playoffs, defending FedExCup champion Justin Thomas completed against NBC’s The Tonight Show Starring Jimmy Fallon in a friendly golf game, with FedEx donating $1 million to St. Jude in honor of the winner.
-
Late effects of treatment hinder independence of adult survivors of childhood brain tumors
08/09/2018
St. Jude investigators find that cognitive impairment and physical performance limitations are strong predictors of non-independence in survivors.
-
Financial checkup should be part of health screenings for childhood cancer survivors
08/01/2018
Financial hardship is widespread among childhood cancer survivors, reducing their quality of life and leaving them at risk for depression, other problems.
-
Solution to medical mystery may help some children avoid bone marrow transplantation
07/26/2018
Researchers identify mutations responsible for an inherited bone marrow disorder and evidence some affected patients may regain normal immune function without treatment.
-
St. Jude collaborates to improve knowledge of childhood cancer worldwide
07/18/2018
The partnership with Institute for Health Metrics and Evaluation will provide more accurate estimates of the global burden of cancer among children.
-
Scientists identify a protein complex that shapes the destiny of T cells
07/06/2018
Metabolic activity in immune cells influences the fate of developing T cells, including a protein complex that plays a decisive role.
-
"Substantial portion" of childhood cancer survivors not concerned about their future health
06/25/2018
Surveys from the Childhood Cancer Survivor Study found that a surprisingly high number of survivors showed a lack of concern for their future well-being.
-
Engineered 'starter key' for brain tumor offers new model for drug testing
06/25/2018
Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
-
St. Jude CEO James Downing ranked No. 5 of Glassdoor’s Top 100 CEOs
06/20/2018
Under Downing’s leadership, St. Jude has increased employee feedback channels and forums, resulting in more innovation and connectivity across the Memphis-based campus.
-
Researchers develop a better method to compare gene expression in single cells
06/19/2018
Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
-
St. Jude partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
06/07/2018
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
-
Rigorous study finds widely used treatment for infection fails young cancer patients
06/05/2018
Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
-
Pediatric cancer research highlighted at ASCO Annual Meeting
05/31/2018
St. Jude experts share pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
-
‘Hidden’ driver discovered that helps prime the anti-tumor immune response
05/30/2018
Read about the algorithm that helped researchers uncover hidden drivers of immune regulation and production of anti-tumor T cells.
-
St. Jude Children's Research Hospital expands international reach with St. Jude Global
05/24/2018
Hospital invests more than $100 million to improve childhood cancer survival rates worldwide.
-
St. Jude trial identifies a medulloblastoma subset that requires less aggressive therapy
05/17/2018
For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
-
‘Lone wolf’ protein offers new pathway to cancer treatments
05/16/2018
The protein called BOK offers another target for drugs to selectively trigger apoptosis.
-
St. Jude named the World Health Organization’s first Collaborating Centre for Childhood Cancer
05/16/2018
St. Jude is partnering with WHO to develop strategies that strengthen the global resources, organization and planning needed to identify and treat pediatric cancer.
-
Genetic counseling and testing proposed for patients with the brain tumor medulloblastoma
05/09/2018
Researchers created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible.
-
Research pinpoints viral mutation that would trigger resistance to new anti-influenza drugs
04/24/2018
Using combination therapy for flu, a new class of drug offers potential for multi-drug therapy and possibly improved influenza-fighting drugs.
-
Discovery adds to evidence that some children are predisposed to develop leukemia
04/19/2018
A family’s history of childhood leukemia leads to the discovery of a fourth gene (IKZF1) that predisposes carriers to pediatric acute lymphoblastic leukemia.
-
St. Jude at AACR 2018
04/12/2018
Explore research and resources by St. Jude at the annual meeting of the American Association for Cancer Research (AACR) in Chicago.
-
St. Jude Cloud, largest public repository of pediatric cancer genomics data, launches for researchers worldwide
04/12/2018
St. Jude to offer next-generation sequencing data and analysis tools to accelerate research and cures for life-threatening pediatric diseases.
